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Abstract
Background: Streptococcus pneumoniae [Sp] infection is associated with local and systemic disease. Our current
understanding of the differential contributions of genetic strain variation, serotype, and host response to disease phenotype
is incomplete. Using the chinchilla model of otitis media [OM] we investigated the disease phenotype generated by the
laboratory strain TIGR4 and each of thirteen clinical strains (BS68-75, BS290, BS291, BS293, BS436 and BS437); eleven of the
thirteen strains have been genomically sequenced.
Methodology/Principal Findings: For each strain 100 colony forming units were injected bilaterally into the tympanic
bullae of 6 young adult chinchillas under general anesthesia. All animals were examined daily for local and systemic disease
by a blinded observer. Pneumatic otoscopy was used to evaluate local disease, and behavioral assessments served as the
measure of systemic disease. Virulence scoring was performed using a 4-point scale to assess four clinical parameters
[severity and rapidity of local disease onset; and severity and rapidity of systemic disease onset] during a 10-day evaluation
period. Highly significant variation was observed among the strains in their ability to cause disease and moribundity.
Conclusions/Significance: As expected, there was a significant correlation between the rapidity of systemic disease onset
and severity of systemic disease; however, there was little correlation between the severity of otoscopic changes and
severity of systemic disease. Importantly, it was observed that different strains of the same serotype produced as broad an
array of disease phenotypes as did strains of different serotypes. We attribute these phenotypic differences among the
strains to the high degree of genomic plasticity that we have previously documented.
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Introduction
Otitis media (OM) is the most common malady for which
children receive medical and surgical attention in the United
States and Europe [1]. Nearly all children will experience an
episode of OM during the first two years of life, and approximately
2 million children receive myringotomies and ventilation tubes
annually with a total treatment cost of nearly five billion dollars
[2–5]. OM has a wide range of clinical presentations [1] and if
untreated can, in rare cases, lead to invasive and systemic disease
states that are associated with moribundity. OM pathogenesis is
multifactorial with pathogen-specific virulence factors, and the
host’s anatomy, immune status, and genetics all playing roles in
phenotypic expression [6–15]. Recent evidence has established
that genetic polymorphisms in the promoter of the human IL-9
gene result in its over expression in response to endotoxin exposure
resulting in increased mortality [8]. Other studies [16–19] have
illuminated the complexities of pathogen-host interactions and
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pathogen virulence factors, as well as specific elements of the host
response make independent contributions to the development of
clinical phenotype providing potential targets for future therapies
[20,21,22].
These investigations continue to yield provocative answers and
questions, but the local and systemic clinical challenges associated
with OM remain. A uniformly predictive way of stratifying risk in
persons with OM that provides for the reliable identification of
persons with self-limited disease or chronic local disease (otitis
media with effusion [OME]) from those with early invasive disease
has been elusive. This difficulty in differentiation exists because the
initial disease presentation for both self-limited, and invasive
infections, are similar.
S. pneumoniae is one of the three bacterial pathogens (together
with Haemophilus influenzae and Moraxella catarrhalis ) most frequently
identified by culture and molecular diagnostics from middle-ear
effusions obtained from children with acute and chronic forms of
OM [23]. This pathogen is also associated with a number of other
important infections including pneumonia, meningitis, bacteremia
and osteomyelitis [24–27]. While over 90 different serotypes of Sp
are known, less than 30 are responsible for over 90% of human
disease [28]. This suggests that serotype is important, but not the
sole determinant of pathogenicity.
In a survey study Shen et al. [29] demonstrated that each of ten
clinical pneumococcal strains varied substantially from each other in
terms of gene content providing support for the distributed genome
hypothesis (DGH) [30]. This study suggested that each strain
contains a unique distribution of genes from a population-based
supragenome [29] that is much larger than the genome of any single
strain. As a direct test of the DGH, Hiller et al. showed in an
exhaustive pair-wise comparison of 17 complete pneumococcal
genomes that on average each clinical strainpair varied (i.e. the gene
was present in one strain and absent in the other) at 18% of their
genic loci [31]. Moreover, this study documented that between 21%
and 33% of the genes in each strain are non-core, or distributed
genes. Thus, each strain contains a unique distribution of genes, not
alleles,froma population-basedsupragenome, whichisfar greater in
size than the genome of any given strain. This observation of
extensive genomic plasticity driven byactive horizontal gene transfer
mechanisms has been widely observed among other pharyngeal
pathogens as well, including Haemophilus influenzae, Neisseria meningi-
ditis, and Streptococcus agalactiae [29,32,33,34].
Previous animal studies of OM using the Chinchilla laniger
(chinchilla) model suggested that this model could differentiate
between both different bacterial species and different clinical
strains of a single species with respect to the severity of both local
and systemic disease [35,36,37]. The gram-negative bacterium
Haemophilus influenzae often yielded lethal, systemic disease
characteristic of fulminant endotoxemia, whereas inoculation with
Sp produced an unpredictable variety of apparently strain-specific
clinical phenotypes.
The objective of this study was to determine if each of fourteen
genetically characterized Sp clinical strains produced a consistent
and unique disease phenotype with respect to type (local or
systemic), rapidity of onset, and severity of disease following
middle-ear inoculation. Future studies will examine the discrete
phenotype/genotype relationships of these strains.
Results
Study Design
We undertook a comparative evaluation of the disease
phenotypes induced by 14 genotypically distinct pneumococcal
strains [29,31], including 5 strains of serotype 9 and 2 strains of
serotype 6, and one unencapsulated strain that was known to cause
localized disease using the chinchilla model of OM (Fig. 1). Strains
will be referred to by their name followed by the serotype within
parenthesis. The rapidity and severity of both otoscopic and
systemic clinical signs for each strain were evaluated on a 4-point
scale using a cohort of 6 animals by a blinded observer (Table 1).
Otoscopic Signs
Across the fourteen strains the rapidity of otoscopic changes,
defined as the days to the development of unambiguous otological
signs (a score of 2 or above since differences between scores of 0
and 1 were difficult to discern, Table 1), produced a mean of
1.93 days61.35 (standard deviation, SD) (Fig. 2). Note, that
animals that never developed otoscopic disease (such as all PBS
controls) were excluded from this set. An ANOVA analysis of the
differences among the strains produced highly significant results
(p-value=9.6e
215) as did repetition of the analysis by the non-
parametric Kruskal-Wallis test (p-value=2.4e
25) (Table 2). The
means for the individual strain cohorts ranged from 1 day for
strains BS291(9), BS75(19) and BS69(14) to 5.5 days for the
unencapsulated strain BS293 and 4.6 for the capsulated strain
BS74(6) (Fig. 2, Table 3). Statistical analysis of all the strain pairs
using Tukey HSD showed that unencapsulated BS293 and
BS74(6), the strains with slowest onset of disease, differed
significantly from strains BS290(9), BS291(9), BS436(9),
BS437(9), BS68(9), BS69(14), BS70(11), BS73(6), BS75(19), and
TIGR4(4). In addition unencapsulated BS293 also differed from
BS71(3). Finally BS72(23) differed significantly from BS291(9),
BS68(9), BS69(14), BS73(6) and BS75(19), the strains with the
fastest onset of disease.
We also analyzed the maximal otologic score for each animal as
a measure for the severity of local disease (where scores of 0 and 1
were considered to be the same since they are hard to discern)
(Fig. 3). The mean score for maximal otologic disease among the
fourteen strains was 2.2660.87. Mean scores for individual strains
ranged from 1.3 for strains BS71(3) and BS72(23) to 2.83 for
strains BS75(19), BS437(9), BS73(6), BS69(14), and TIGR4(4)
(Table 3). Statistical analysis of this data set showed a significant
difference amongst the strains (ANOVA p-value=9.56e
25, and
Figure 1. The transbullar technique is used to induce S.
pneumoniae otitis media in the chinchilla under general
anesthesia.
doi:10.1371/journal.pone.0001969.g001
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Otologic Score 0 1 2 3 4
Degree of otoscopic
disease
none Mild Moderate Frank purulence Tympanic membrane
rupture
Systemic Score 0 0.5 1 2 3 4
Systemic Disease normal Slightly lethargic
Upright and steady
on feet Immediately
responds to
stimulation by
actively moving
around cage Eating
and drinking
Slightly lethargic Upright and
steady on feet Head and ears
down Responds by actively
moving around cage rapidly
when stimulated by voice or
touch Eating and drinking
Eyes K open
Moderately lethargic
Slightly ataxic Able to
keep self upright Moving
around cage slowly only
when stimulated by voice
or touch Eating treats
and drinking water
Same as 2 but not
eating or drinking
Extremely lethargic
Extremely ataxic Not able
to maintain an upright
position Barely moving
around cage Dyspnea
Considered Moribund
doi:10.1371/journal.pone.0001969.t001
Figure 2. Rapidity of otologic disease onset. Scatter plot showing the number of days it took for chinchillas inoculated with each of the S.
pneumoniae clinical strains to develop moderate or worse (score $2) otologic disease, where each triangle represents a single animal. Statistical
analysis of all the strains revealed a significant difference, the p-value for the ANOVA analysis was 9.6e
215, and for the Kruskal-Wallis test was 2.4e
25.
Animals are not included that did not develop local disease before the end of the experiment or before reaching a moribund state. Colors represent
different serotypes, and shades of the same color different strains of the same serotype or in the case of BS68(9) two cohorts from different
experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g002
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all the strain pairs using Tukey HSD, showed that the strains with
the least severe otoscopic disease BS71(3) and BS72(23) differed
significantly from BS437(9), BS69(14), BS73(6), BS75-19, and
TIGR4(4). There was a significant correlation between days to
onset of otoscopic disease and the maximal otoscopic score
(Spearman’s rank correlation rho=20.311 with p-value=0.009).
Animals that were inoculated with BS71(3) and BS72(23)
rapidly displayed signs of systemic moribundity, which effected our
ability to gauge the development of otoscopic disease past day 2
(Fig. 4). Importantly, many strains show otoscopic changes by day
1 or 2 (Fig. 2), demonstrating that systemic moribundity by day 2
does not prohibit the development of otoscopic signs, as is most
evident for strain BS68(9), which showed high otologic scores by
day 2 (Fig. 3 and 4). Nonetheless, to account for the affect of the
loss of animals infected with systemically virulent strains on the
strain’s otoscopic scores, we performed Kaplan-Meier Survival
Probability Estimates. These results confirmed that days to onset
of otoscopic disease were significantly different between the strains
(the log-rank test for days to onset of moderate or worse otologic
disease had a p-value=6.446e
212, Table 2).
Systemic Signs
The rapidity of the development of systemic signs across all
fourteen strains produced a mean of 2.3 days61.6 (Fig. 5). Table 1
describes the signs of systemic disease for which the animals were
monitored, scores of 0.5 and above were considered, and animals
that never developed systemic signs were excluded from the
Table 2. Summary of All Statistical Analysis
Group Parameter ANOVA Kruskal-Wallis Kaplan-Meier Fisher-Exact
All Otoscopic Rapidity 9.60E-15 2.42E-05 6.44E-12 N/A
All Otoscopic Severity 9.56E-05 0.00118 N/A N/A
All Systemic Rapidity 0.09392 0.01637 N/A N/A
All Systemic Rapidity 2* 0.03066 0.001187 N/A N/A
All Systemic Severity 2.69E-09 4.22E-06 N/A N/A
All Moribundity N/A N/A N/A 3.90E-07
Capsulated Systemic Rapidity 0.106 0.02055 N/A N/A
Capsulated Systemic Rapidity 2* 0.03066 0.001187 N/A N/A
Capsulated Systemic Severity 1.22E-05 0.000171 N/A N/A
Capsulated Moribundity N/A N/A N/A 0.000117
Serotype 9 Otoscopic Rapidity 0.007666 0.01092 N/A N/A
Serotype 9 Otoscopic Severity 0.3475 0.4509 N/A N/A
Serotype 9 Systemic Rapidity 0.1116 0.04126 N/A N/A
Serotype 9 Systemic Rapidity 2* 0.001299 0.001762 N/A N/A
Serotype 9 Systemic Severity 1.77E-01 1.84E-01 N/A N/A
*Systemic Rapidity 2 measured onset to moderate or worst systemic disease (score $2)
N/A: not applicable.
doi:10.1371/journal.pone.0001969.t002
Table 3. Averages and standard deviations observed within each strain for local and systemic disease
Parameter BS68 BS290 BS291 BS436 BS437 BS293 BS73
otoscopic rapidity (days) 1.41760.515 1.83360.408 1602 . 1 6 7 60.408 1.66760.816 5.560.577 1.16760.408
otoscope severity 2.58360.669 2.16760.408 2.260.447 2.33360.516 2.83360.983 1.66760.516 2.83360.408
rapidity to any systemic disease (days) 1.58360.515 463.95 2603 61.414 2.860.447 260 3.33362.875
rapidity to moderate or worse systemic
disease (days)
2.09160.539 3.33360.577 2.860.447 3.660.894 461.414 NA 3.562.739
systemic severity 3.7560.866 2.2561.917 4603 . 3 3 3 61.633 2.7561.943 0.560 3.66760.816
Parameter BS75 BS69 TIGR4 BS71 BS72 BS70 BS74
otoscopic rapidity (days) 1601 602 61.095 2 4 2.560.707 4.66762.082
otoscope severity 2.83360.983 2.83360.408 2.83360.753 1.33360.816 1.33360.816 1.66761.033 1.83360.983
rapidity to any systemic disease (days) 1.66760.516 361.673 3601 . 5 60.548 1.66760.516 1.66760.816 2.561
rapidity to moderate
or worse systemic disease (days)
1.83360.408 361.673 3601 . 5 60.548 2.16761.472 1.83361.169 2.561
systemic severity 460 3.66760.516 0.66761.033 4604 604 60 2.561.975
N/A: non-applicable.
doi:10.1371/journal.pone.0001969.t003
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1.58 days for BS68(9) to 4 days for BS290(9) (Table 3). Analysis of
this data using ANOVA does not show any statistical significance
amongst the strains, however, repetition of the analysis by the non-
parametric Kruskal-Wallis test yielded a statistically significant p-
value of 0.016 (Table 2). Since even healthy animals showed
slightly lethargic behavior (score 0.5), as evident by the PBS
control, we also analyzed the days to onset of moderate or worse
systemic disease (only scores of 2 or above; thus all animals that did
not develop at least moderate symptoms were excluded from this
analysis) (Fig. 6). These values range from 1.5 days for BS71(3) to
4 days for BS437(9) (Table 3). The results showed a significant
difference amongst all strains (ANOVA p-value=0.03, Kruskal-
Wallis test p-value= 0.001) (Table 2).
The maximum systemic severity score was highly significantly
different amongst strains (ANOVA p-value= 2.69e
29 and
Kruskal-Wallis p-value=4.22e
26)(Table 2, Fig. 7). The mean
score for all fourteen strains was 3.1161.52. It ranged from 0.5 for
the unencapsulated strain BS293 (as well as the PBS control) to
4 for strains BS291(9), BS75(19), BS71(3), BS72(23), and
BS70(11), where all animals demonstrated moribundity (Table 3).
Tukey-HSD analysis of all the strain pairs showed that the
unencapsulated strain BS293 and TIGR4(4) differed significantly
from BS291(9), BS436(9), BS68(9), BS69(14), BS70(11), BS71(3),
BS72(23), BS73(6), BS75(19), in addition BS293 also differed from
BS437(9).
There was a significant correlation between severity of otoscopic
disease and systemic rapidity (Spearman’s rank correlation
rho=0.42 with p=1.9e
24), and between severity and rapidity of
systemic disease (Spearman’s rank correlation rho=20.30 with
p=5.95e
23); while there was no significant correlation between
otoscopic and systemic severity.
Unencapsulated strains are not thought to cause systemic
disease, thus we repeated the systemic score statistical analyses
using only the capsulated strains (Table 2). Systemic severity scores
were also highly significantly different amongst the encapsulated
strains (ANOVA p-value =1.22e
25, and Kruskal-Wallis p-
value=0.000171). Note that the onset of moderate or worse
systemic disease has the same p-value as amongst all strains, since
the unencapsulated strain never reaches moderate or worse disease
and thus was already excluded from this analysis.
Strain Specific Moribundity. The moribundity of the
chinchillas differed significantly amongst the strains, as
determined by Fisher’s Exact test (p-value=3.9e
27) (Table 2).
Figure 3. Severity of otoscopic change. Scatter plot illustrating the maximal otologic score for each animal inoculated with each of the S.
pneumoniae strains, where each triangle represents a single animal. Statistical analysis of all the strains revealed a significant difference (ANOVA p-
value=9.56e
25 and Kruskal-Wallis p-value= 0.00118). Colors represent different serotypes, and shades of the same color different strains of the same
serotype or in the case of BS68(9) two cohorts from different experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g003
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the most lethal, producing 100 % moribundity within the cohorts;
in contrast, no animals inoculated with TIGR4(4) and BS293-
nonencapsulated reached a state of moribundity (Table 4). Again,
since unencapsulated strains are not thought to cause systemic
disease the Fisher’s Exact test was repeated amongst just the
capsulated strains, confirming that there are major differences in
moribundity among the encapsulated strains (p-value=0.000117).
Intra-serotype Specific Statistical Tests. We evaluated
five independent serotype 9 strains (BS68, BS290, BS291, BS436,
and BS437) to determine if the entire range of clinical phenotypes
observed among the 9 strains, each with a unique serotype, would
be present within a single serotype as a test to determine if total
genotype (as opposed to serotype alone) played an important role
in disease phenotype.
Analysis of the rapidity of otoscopic changes showed a
significant difference among the five serotype 9 strains (ANOVA
p-value= 0.008, Kruskal-Wallis p-value=0.01) (Table 2). The
mean was 1.6 days60.6, and the individual strain means ranged
from 1 for BS291 to 2.16 for BS436 (Fig. 2, Table 3). No statistical
differences were observed in otoscopic severity among the five
serotype 9 strains (Table 2), which had a mean score of 2.4560.65.
There were no significant differences amongst the serotype 9
group for rapidity of onset of systemic disease, the mean was
2.48 days61.9 (this is not surprising since this score was also not
significant amongst all strains) (Fig. 5). In contrast, the onset of
moderate or worse systemic disease is significantly different
amongst the serotype 9 group (ANOVA p-value=0.001 and
Kruskal-Wallis p-value=0.0017) (Table 2, Fig. 6). Finally, the
difference for systemic severity scores amongst serotype 9 strains
was not significant (ANOVA p-value=0.17 and Kruskal-Wallis p-
value=0.18). The mean score was 3.2861.4, which ranges from
2.25 for BS290 to 4 for BS291 (Table 3 and Fig. 7).
Discussion
The chinchilla OM model provides a useful and facile system to
study the spectrum of disease induced by multiple clinical Sp
strains of unique genotype. In the current study we used an
objective clinical scoring system [38] to investigate the differences
in virulence induced by a collection of Sp strains that included 8 of
the serotypes most frequently associated with OM, including
multiple isolates of serotype 9. These data established that
individual strains, even within a single serotype, have a wide
Figure 4. Days to moribund condition. Scatter plot illustrating the timing to the development of a moribund condition for each of the fourteen
pneumococcal strains in the chinchilla model of otitis media. No moribundity was observed in the cohorts inoculated with TIGR4(4) or the
unencapsulated strain BS293. Each triangle represents a single animal. Colors represent different serotypes, and shades of the same color different
strains of the same serotype or in the case of BS68(9) two cohorts from different experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g004
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systemic disease, and that there is little if any linkage between a
strain’s propensity to induce local and systemic signs, most evident
by TIGR4(4) that induced strong local disease but very mild
systemic changes. The variation amongst animals within cohorts
was lower than the variation amongst all cohorts suggesting that
the bacterial strain type plays a major factor in pathogenesis,
however, the genetic background of the host is also clearly
important as there is variability of disease within a cohort of
animals infected with a single isolate. It is important to remember
that the chinchillas used in these studies are of outbreed stock and
are therefore genetically heterogeneous. Thus, they would not
necessarily be expected to have a stereotypic host response.
An example of the Sp strain-specific effects can be seen by the
large difference in local effects induced by BS71(3) and BS72(23)
relative to BS75(19), BS437(9), BS73(6), BS69(14) and TIGR4(4).
Similarly, the strain-specific systemic effects were highly significant
when comparing strains BS70(11), BS71(3), BS72(23), BS75(19),
and BS291(9) with TIGR4(4) and unencapsulated BS293. Strains
BS437(9) and TIGR4(4), which caused significant local disease,
were only average or mild in their systemic virulence, respectively.
Similarly, some strains that produced rapid, fulminant systemic
signs (strains BS70(11), BS71(3) and BS72(23)) did not cause
clinically important local disease. This dichotomy may be due to
one or more of several factors. However, it is likely that a major
contributor to the observed differences in disease results from the
unique combination of virulence genes that each strain possesses
[29,31]. The clinically different disease states presented by several
strains, with the same serotype (9), strongly suggest that
configuration of the capsular polysaccharides that confer serotype
may not always play a major role in the disease process.
Interestingly, the unencapsulated strain BS293, which causes
significant localized disease, was obtained from the same patient at
two separate clinic visits 23 days apart suggesting that this is a
persistent unecapsulated strain (manuscript in preparation, Hiller,
Hu, and Ehrlich).
We have recently completed whole genome sequencing on 11 of
the 13 clinical strains evaluated in this study, which revealed very
extensive genomic plasticity among them [31] and unpublished
data. After annotating each genome, a conservative gene
clustering algorithm was used [39] to bin together orthologous
genes from the different strains to ensure that simple allelic
Figure 5. Rapidity of onset of any systemic disease signs. Scatter plot showing the number of days it took for chinchillas inoculated with each
of the S. pneumoniae strains to develop any signs of systemic disease (score .0). Statistical analysis of all the strains did not reveal a significant
difference among them. Each triangle represents a single animal. Animals are not included that did not develop disease before the end of the
experiment. Colors represent different serotypes, and shades of the same color different strains of the same serotype or in the case of BS68(9) two
cohorts from different experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g005
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The gene clustering results were then used for the performance of
global (all strains together) genome-wide comparisons to determine
the number of core genes, those present in all strains, as well as the
number of distributed and unique genes present in each strain and
collectively within a 24 strain supragenome. These analyses were
followed by the performance of an exhaustive set of pair-wise genic
comparisons across all strains, which showed that on average each
strain varied from every other strain by the gain or loss of nearly
400 gene clusters. Since on average each strain pair only contains
1795 gene clusters in common this means that ,18% of each
genome is unique with respect to every other genome on average.
Included among the distributed and unique gene sets for each of
these strains were a large number of candidate virulence genes,
many of which have not been previously identified among the
pneumococci [29]. One such example includes a cluster of 10
adjacent genes that are always found together, such that if a strain
possesses one of them it possesses all of them suggesting that these
genes may represent a previously unrecognized mobile genetic
element particularly as one of the genes annotates as an integrase.
This gene cluster is possessed by all of the highly virulent strains
including BS70(11), BS75(19), BS72(23), BS71(3), BS291(9), and is
also found in one of the intermediately virulent strains, BS68(9), as
well as one of the less virulent strains BS290(9), but is absent
among the remainder of the avirulent and intermediately virulent
strains including TIGR4(4), BS74(18), BS69(14), and BS73(6).
These genes are also present in the systemically avirulent
unencapsulated strain BS293, but this strain’s lack of systemic
virulence is attributable to its lack of capsule. Five of these ten
genes are organized into one operon and have been annotated as
being involved in cellobiose PTS transport and metabolism. This is
interesting because McKessar and colleagues (2007) previously
showed that disruption of one of the virulence-related two-
component systems in Sp, TCS08, resulted in suppression of a
putative cellobiose transport system (PTS)[40]. The PTS system
we have identified is only distantly related to the one described by
McKessar et al. with some of the components having very limited
identity (30–40%) and others which show no measurable identity
whatsoever. Nonetheless, their results suggest that PTS cellobiose
systems may play a role in virulence; making the PTS system
Figure 6. Rapidity of onset of moderate or worse systemic signs. Scatter plot showing the number of days it took for chinchillas inoculated
with each of the S. pneumoniae strains to develop moderate or worse signs of systemic disease (score $2). Statistical analysis of all the strains
revealed a significant difference (ANOVA p-value=0.03 and Kruskal-Wallis p-value= 0.00118). Each triangle represents a single animal. Animals were
not included that did not develop systemic disease before the end of the experiment. Colors represent different serotypes, and shades of the same
color different strains of the same serotype or in the case of BS68(9) two cohorts from different experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g006
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systemic virulence based upon its segregation largely within the
more highly systemically virulent strains. Together these genomic
and phenotypic studies suggest that the virulence factors for local
and systemic disease may be unique and that some strains have
accumulated more of one class than another, whereas some strains
have accumulated genes from both classes. Moreover, it is clear
that serotype replacement occurs amongst Sp strains, suggesting
that strains that are very genetically diverse may share the same
serotype, likewise strains that are highly related may have different
serotypes. We have observed strain evolution in vivo that has
resulted in as much as 20% genome replacement by a donor strain
(Hiller et al. unpublished observations). Genome sequencing of
multiple Sp strains confirms this, since strains of the same serotype
are often spread apart in a phylogenic comparison based on genic
differences [31]. This enormous plasticity of Sp strains makes it
Figure 7. Severity of systemic signs. Scatter plot illustrating the maximal systemic score for each animal inoculated with each of the S.
pneumoniae strains, where each triangle represents a single animal. Statistical analysis of all the strains revealed a significant difference (ANOVA p-
value=2.69e
29 and Kruskal-Wallis p-value=4.2
26). Colors represent different serotypes, and shades of the same color different strains of the same
serotype or in the case of BS68(9) two cohorts from different experiments. NA: non applicable.
doi:10.1371/journal.pone.0001969.g007
Table 4. Strain Specific Moribundity.
Strain BS290 BS291 BS293 BS436 BS437 BS68 BS69 BS70 BS71 BS72 BS73 BS74 BS75 TIGR4
Serotype 9 9 NA 9 9 9 14 11 3 23 6 6 19 4
Moribundity
F A L S E30612120001306
T R U E 350541 1 4 6 6 65360
Fisher-Exact Test comparing all strains: p-value=3.9e
27 and comparing capsulated strains: P-value=0.000117.
NA: Not Applicable
doi:10.1371/journal.pone.0001969.t004
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geographic regions what the pathogenicity of any specific strain or
serotype will be.
The observation that there is extensive genomic plasticity
among Sp strains does not preclude the contribution of unique host
factors to clinical phenotype and outcome. Such host factors could
include differing expression levels of certain immune system
components that may affect susceptibility or resistance to certain
pathogens [10,41,42].
Induction of OM in the chinchilla results in a reproducible
model of local infection that reliably mimics the clinical disease.
The dichotomy between a strain’s proclivity to cause local and
systemic disease is entirely consistent with the spectrum of human
disease caused by Sp. The clinical challenge remains to
differentiate those patient-strain combinations that will result in
infectious spread by invasion or dispersion, from those that will
have self-limited disease. This model provides the unique
opportunity to separate pathogen weaponry from host response.
Materials and Methods
Bacterial strains and culture
Thirteen pneumococcal strains (all ampicillin sensitive) were
obtained as nasal washes from symptomatic pediatric participants
at Children’s Hospital of Pittsburgh who were enrolled in a
Fluzone vaccine trial. All clinical S. pneumoniae strains were isolated
and restreaked for single colonies on Trypticase
TM Soy Agar (TSA
II) supplemented with 5% sheep’s blood (Becton Dickinson,
Sparks, MD), and then cultured in Todd Hewitt broth (Sigma, St.
Louis, MO) at 37uC in a humidified 5% CO2 atmosphere for one
passage followed by aliquotting and cryopreservation in 22%
glycerol at –80uC. Pneumococcal isolates were typed by the
Quellung reaction using polyvalent serogroup and serotype-
specific antisera (Statens Seruminstitut, Copenhagen, Denmark).
The eleven strains, designated as BS68-75, BS290, BS291, BS436,
BS437, BS293, were serotyped as types 9V, 14, 11, 3, 23F, 6A, 6A,
19F, 9V, 9V, 9V, 9V and nontypeable, respectively. The TIGR4
(BS90, serotype 4) strain was also obtained and plated. Eleven of
the thirteen (excluding BS436 and BS437) clinical strains have
been completely sequenced to an average depth of coverage of
.20-fold and have been demonstrated to be unique with respect
to their genic content [29,31]. Middle-ear inocula for each strain
were prepared by plating one of the first passage aliquots on blood
agar for overnight incubation. Chinchillas were inoculated
bilaterally with ,100 CFU/ear based on cultures with an
ODA600 of 1 of having 5610
8 CFU/mL. The actual inoculating
titers were determined by standard dilutional plate counts.
Animal experiments and monitoring
All experiments were conducted with the approval of the local
Institutional Animal Care and Use Committee (IACUC).
Research grade young adult chinchillas (C. laniger, 400–600 gm;
McClenahan Chinchilla Ranch, New Wilmington, PA) were
obtained free of middle-ear disease. After a protocol-directed
period of environmental acclimation, induction of anesthesia was
attained on day 0 by intramuscular injection of 0.1 mL of a
solution of ketamine hydrochloride 100 mg/mL, xylazine hydro-
chloride 30 mg/mL and acepromazine 5 mg/mL. After anesthe-
sia was confirmed (abolishment of the eye-blink reflex), 0.1 mL of
a 1000 CFU/mL Sp culture was injected bilaterally into the
tympanic bullae using a 0.5 in, 27-gauge needle attached to a 1 ml
syringe (Fig. 1). Each of the fourteen pneumococcal strains was
used to infect a cohort of 6 chinchillas. BS68 was inoculated into
two cohorts of 6 chinchillas to ensure experimental consistency
across temporally distinct inoculation groups; the data from the
two BS68 groups were combined for statistical analysis. Impor-
tantly, there was no statistically significant difference between the
two BS68-inoculated sets using both parametric and non-
parametric tests. The BS291 cohort was reduced to 5 due to a
death unrelated to the experiment.
A multiparameter scoring system based on signs of local and
systemic disease (Table 1) was applied to each chinchilla on a daily
basis for ten days to assess the degree of disease induced by the
individual pneumococcal strains. All clinical evaluations were
performed by an otoscopist who was blinded with respect to the
strains that had been used to inoculate each animal. This scale has
demonstrated utility in clinical scoring of the chinchilla’s response
to direct bacterial inoculation of the bullae [38]. A control cohort
of 6 animals was inoculated with sterile phosphate buffered saline.
Moribund animals (having a systemic severity score of 4) were
either treated with 150-mg/kg ampicillin daily (all Sp strains were
ampicillin sensitive) or sacrificed in accordance with the IACUC
protocol. Once an animal reached this state evaluation ceased, as
moribundity was considered an end point.
Statistical Analysis
Raw scores for local and systemic disease ranged from 0
(clinically normal) to 4 (extreme severity) (Table 1) and
moribundity was recorded (Table 4). Results are reported as
mean6standard deviation (SD). One-way ANOVA and Kruskall-
Wallis tests were utilized in comparisons across cohorts to
determine if the differences in local and systemic diseases were
statistically significant among strains. Tukey’s HSD test was
utilized for pairwise comparisons between strains. The Fisher
Exact test was utilized to examine the statistical significance of
moribundity data across all cohorts (Table 4). Kaplan Meier
estimates were utilized to perform log-rank tests that measure for
strain differences in local disease onset. Significance was defined as
p-value #0.05. The open source software package R was utilized
for all statistical analysis (http://www.r-project.org/).
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